Dendritic cell-based immunotherapy

被引：630
|
作者：
Sabado, Rachel L. [1 ]
Balan, Sreekumar [1 ]
Bhardwaj, Nina [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
来源：
CELL RESEARCH | 2017年 / 27卷 / 01期
关键词：
dendritic cell; immunotherapy; CERVICAL-CANCER PATIENTS; REGULATORY T-CELLS; INTEGRATED IMMUNE-RESPONSE; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IN-VIVO; SIPULEUCEL-T; LYMPH-NODES; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY;
D O I：
10.1038/cr.2016.157
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.
引用
收藏
页码：74 / 95
页数：22
相关论文
共 50 条
  • [1] Nanoparticles for dendritic cell-based immunotherapy
    Tuan Hiep Tran
    Thi Thu Phuong Tran
    Hanh Thuy Nguyen
    Cao Dai Phung
    Jeong, Jee-Heon
    Stenzel, Martina H.
    Jin, Sung Giu
    Yong, Chul Soon
    Duy Hieu Truong
    Kim, Jong Oh
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 542 (1-2) : 253 - 265
  • [2] Dendritic cell immunotherapy
    Sabado, Rachel Lubong
    Bhardwaj, Nina
    RENAISSANCE OF CANCER IMMUNOTHERAPY, 2013, 1284 : 31 - 45
  • [3] Dendritic cell-based immunotherapy
    Rachel L Sabado
    Sreekumar Balan
    Nina Bhardwaj
    Cell Research, 2017, 27 : 74 - 95
  • [4] Dendritic cell-based immunotherapy
    Osada, Takuya
    Clay, Timothy M.
    Woo, Christopher Y.
    Morse, Michael A.
    Lyerly, H. Kim
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2006, 25 (5-6) : 377 - 413
  • [5] Personalized dendritic cell-based tumor immunotherapy
    Janikashvili, Nona
    Larmonier, Nicolas
    Katsanis, Emmanuel
    IMMUNOTHERAPY, 2010, 2 (01) : 57 - 68
  • [6] Potential approaches for more successful dendritic cell-based immunotherapy
    Chiang, Cheryl Lai-Lai
    Balint, Klara
    Coukos, George
    Kandalaft, Lana E.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (04) : 569 - 582
  • [7] Dendritic cell-based immunotherapy in mesothelioma
    Cornelissen, Robin
    Lievense, Lysanne A.
    Heuvers, Marlies E.
    Maat, Alexander P.
    Hendriks, Rudi W.
    Hoogsteden, Henk C.
    Hegmans, Joost P.
    Aerts, Joachim G.
    IMMUNOTHERAPY, 2012, 4 (10) : 1011 - 1022
  • [8] Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
    Qian, Chen
    Yang, Li-Jun
    Cui, Hong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
    Bol, Kalijn F.
    Schreibelt, Gerty
    Gerritsen, Winald R.
    de Vries, I. Jolanda M.
    Figdor, Carl G.
    CLINICAL CANCER RESEARCH, 2016, 22 (08) : 1897 - 1906
  • [10] Dendritic cell-based cancer immunotherapy for pancreatic cancer
    Li, Wei
    Song, Xiujun
    Yu, Huijie
    Zhang, Manze
    Li, Fengsheng
    Cao, Cheng
    Jiang, Qisheng
    ARAB JOURNAL OF GASTROENTEROLOGY, 2018, 19 (01) : 1 - 6
12345